Selection of antisense oligonucleotides based on multiple predicted target mRNA structures

Selection of antisense oligonucleotides based on multiple predicted target mRNA structures

<p>Abstract</p> <p>Background</p> <p>Local structures of target mRNAs play a significant role in determining the efficacies of antisense oligonucleotides (ODNs), but some structure-based target site selection methods are limited by uncertainties in RNA secondary structu...

Full description

Bibliographic Details
Main Authors:	Yang Jing, Shu Wenjie, Sun Daochun, Lou Shaoke, Bo Xiaochen, Wang Shengqi
Format:	Article
Language:	English
Published:	BMC 2006-03-01
Series:	BMC Bioinformatics
Online Access:	http://www.biomedcentral.com/1471-2105/7/122

Similar Items

Thermodynamics and kinetics of antisense oligonucleotide hybridization to a structured mRNA target
by: Walton, S. Patrick (Stephen Patrick), 1973-
Published: (2008)

Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
by: Kristin A. Ham, et al.
Published: (2021-07-01)

Selective targeting of MYC by antisense oligonucleotides
by: Gill, Taylor Elizabeth
Published: (2018)

Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD)
by: Eugénie Ansseau, et al.
Published: (2017-03-01)

Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms.
by: Timothy A Vickers, et al.
Published: (2014-01-01)

Dynamics of co-transcriptional pre-mRNA folding influences the induction of dystrophin exon skipping by antisense oligonucleotides.
by: Keng Boon Wee, et al.
Published: (2008-01-01)

Modulation of dystrophin pre-mRNA splicing by antisense oligonucleotides : a potential therapy for Duchenne muscular dystrophy
by: Thorogood, Francesca Clare
Published: (2007)

The process of target mRNA degradation in Antisense and sense gene silencing
by: Shaharuddin, Noor A.
Published: (2007)

The cellular uptake of antisense oligonucleotid of E6 mRNA into cervical cancer cells by DOPE-modified hydroxyapatite nanoparticles
by: Negin Saffarzadeh, et al.
Published: (2014-10-01)

From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides
by: Atze J Bergsma, et al.
Published: (2016-01-01)

Cytoplasmic Control of Sense-Antisense mRNA Pairs
by: Flore Sinturel, et al.
Published: (2015-09-01)

Antisense Oligonucleotide- and CRISPR-Cas9-Mediated Rescue of mRNA Splicing for a Deep Intronic CLRN1 Mutation
by: Anna-Lena Panagiotopoulos, et al.
Published: (2020-09-01)

Corrigendum to “From Cryptic Toward Canonical Pre-mRNA Splicing in Pompe Disease: a Pipeline for the Development of Antisense Oligonucleotides”
Published: (2016-01-01)

A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides.
by: Dorota Magner, et al.
Published: (2015-01-01)

Defining the factors that contribute to on-target specificity of antisense oligonucleotides.
by: Walt F Lima, et al.
Published: (2014-01-01)

The study of antisense oligonucleotides delivery by Tf-targeted liposomes
by: Jung-Ying Chen, et al.
Published: (2009)

Correction: A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides.
by: Dorota Magner, et al.
Published: (2016-01-01)

Modulation of p53 expression using antisense oligonucleotides complementary to the 5'-terminal region of p53 mRNA in vitro and in the living cells.
by: Agnieszka Gorska, et al.
Published: (2013-01-01)

The Role of Structural Elements of the 5'-Terminal Region of p53 mRNA in Translation under Stress Conditions Assayed by the Antisense Oligonucleotide Approach.
by: Agata Swiatkowska, et al.
Published: (2015-01-01)

PEGylation of mRNA by Hybridization of Complementary PEG-RNA Oligonucleotides Stabilizes mRNA without Using Cationic Materials
by: Naoto Yoshinaga, et al.
Published: (2021-05-01)

Cytoplasmic control of sense-antisense mRNA pairs in Saccharomyces cerevisiae
by: Navickas, Albertas
Published: (2016)

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
by: Sarah Bajan, et al.
Published: (2020-01-01)

Antisense oligonucleotides in neurological disorders
by: Claudia D. Wurster, et al.
Published: (2018-05-01)

Mannosylated Chitosan Nanoparticles for Delivery of Antisense Oligonucleotides for Macrophage Targeting
by: Gyati Shilakari Asthana, et al.
Published: (2014-01-01)

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
by: Bao T. Le, et al.
Published: (2019-03-01)

Fluorinated Nucleotide Modifications Modulate Allele Selectivity of SNP-Targeting Antisense Oligonucleotides
by: Michael E. Østergaard, et al.
Published: (2017-06-01)

PFRED: A computational platform for siRNA and antisense oligonucleotides design.
by: Simone Sciabola, et al.
Published: (2021-01-01)

Peptide-mediated Cell and In Vivo Delivery of Antisense Oligonucleotides and siRNA
by: Peter Järver, et al.
Published: (2012-01-01)

Inhibition of leukemic apoptosis by antisense oligonucleotide.
Published: (1995)

Silencing Antibiotic Resistance with Antisense Oligonucleotides
by: Saumya Jani, et al.
Published: (2021-04-01)

History of Research on Antisense Oligonucleotide Analogs
by: Jack S. Cohen
Published: (2021-03-01)

Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
by: Zhenxun Wang, et al.
Published: (2012-01-01)

Retracted: Mannosylated Chitosan Nanoparticles for Delivery of Antisense Oligonucleotides for Macrophage Targeting
by: BioMed Research International
Published: (2021-01-01)

Targeting several CAG expansion diseases by a single antisense oligonucleotide.
by: Melvin M Evers, et al.
Published: (2011-01-01)

Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides
by: James T. March, et al.
Published: (2018-06-01)

Using Desferoxamine to Enhance Transferrin Receptor-Targeted Antisense Oligonucleotides Delivery
by: Jyun-Tsang He, et al.
Published: (2010)

Allele-Selective Knockdown of MYH7 Using Antisense Oligonucleotides
by: Brian R. Anderson, et al.
Published: (2020-03-01)

The Use of Antisense Oligonucleotides in Evaluating Survivin as a Therapeutic Target for Radiation Sensitization in Lung Cancer
by: Shinohara Eric T., et al.
Published: (2004-01-01)

An Antisense Oligonucleotide against a Splicing Enhancer Sequence within Exon 1 of the MSTN Gene Inhibits Pre-mRNA Maturation to Act as a Novel Myostatin Inhibitor
by: Farea, M., et al.
Published: (2022)

Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon.
by: Yimin Hua, et al.
Published: (2007-04-01)

Cannot write session to /tmp/vufind_sessions/sess_p7gr9b6f2rpvj87efis6aalgmd